18 Results found
The Endurant II Stent Graft System treats infrarenal abdominal aortic or aorto-iliac aneurysms using an endovascular approach (EVAR). When placed within the aneurysm, the Endurant II Stent Graft provides a permanent, alternative conduit for blood flow within the patient's vasculature.
The Talent thoracic stent graft is pre-loaded into the Captivia delivery system. The loaded delivery system is inserted endoluminally via the femoral or iliac artery and tracked through the patient's vasculature to deliver the stent graft to the target site.
The Absolute Pro Vascular Self-Expanding Stent System is indicated for improving luminal diameter in patients with de novo or restenotic atherosclerotic lesions in the native common iliac artery and native external iliac artery with reference vessel diameters between 4.3 mm to 9.1 mm and lesion leng ....More Details
The Absorb GT1 Bioresorbable Vascular Scaffold (BVS) is a temporary scaffold that will fully resorb over time and is indicated for improving coronary luminal diameter in patients with ischemic heart disease due to de novo native coronary artery lesions (length less than 24 mm) with a reference vesse ....More Details
The XIENCE Family of Everolimus Eluting Coronary Stent Systems are indicated for improving coronary luminal diameter in patients, including those with diabetes mellitus, with symptomatic heart disease due to de novo native coronary artery lesions for XIENCE V (length less than or equal to 28 mm), XI ....More Details
The Xact Carotid Stent System, used in conjunction with the Emboshield Embolic Protection System is indicated for the improvement of the lumen diameter of carotid arteries in patients considered at high risk for adverse events from carotid endarterectomy who require percutaneous carotid angioplasty ....More Details
W.L. Gore & Associates
The GORE VIABIL Short Wire Biliary Endoprosthesis is a fully covered metal stent intended for palliation of malignant strictures in the biliary tree. Unique anti-migration technology aids in reducing the risk of re-interventions.
Total Revenue: $ 2700000000
Avg. Surgery Time: 1 Hours
Avg. Recovery Time: 1-2 Weeks